These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11260285)

  • 21. Recombinant factor VIIa for intracranial haemorrhage in a Jehovah's Witness with severe haemophilia A and factor VIII inhibitors.
    Majumdar G; Savidge GF
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1031-3. PubMed ID: 8148476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia].
    Meili EO; Dazzi H; von Felten A
    Schweiz Med Wochenschr; 1995 Mar; 125(9):405-11. PubMed ID: 7892567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of pegylated full-length recombinant factor VIII with extended half-life for perioperative haemostasis in haemophilia A patients.
    Brand B; Gruppo R; Wynn TT; Griskevicius L; Lopez Fernandez MF; Chapman M; Dvorak T; Pavlova BG; Abbuehl BE
    Haemophilia; 2016 Jul; 22(4):e251-8. PubMed ID: 27328112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decline of factor VIII and factor IX inhibitors during long-term treatment with NovoSeven.
    Johannessen M; Andreasen RB; Nordfang O
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):239-42. PubMed ID: 10870803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uncomplicated neurosurgical resection of a malignant glioneuronal tumour under haemostatic cover of rFVIIa in a severe haemophilia patient with a high-titre inhibitor: a case report and literature review of rFVIIa use in major surgeries.
    Aouba A; Dezamis E; Sermet A; Rothschild C; Hermine O; Lasne D; Torchet MF
    Haemophilia; 2010 Jan; 16(1):54-60. PubMed ID: 19709314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitor antibodies to factor VIII and factor IX: management.
    Lusher JM
    Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous factor VIII infusion therapy in patients with haemophilia A undergoing surgical procedures with plasma-derived or recombinant factor VIII concentrates.
    Dingli D; Gastineau DA; Gilchrist GS; Nichols WL; Wilke JL
    Haemophilia; 2002 Sep; 8(5):629-34. PubMed ID: 12199670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. General haemostatic agents--fact or fiction?
    Hedner U
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():33-6. PubMed ID: 12214145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant factor VIIa in continuous infusion during central line insertion in a child with factor VIII high-titre inhibitor.
    Montoro JB; Altisent C; Pico M; Cabañas MJ; Vila M; Puig LL
    Haemophilia; 1998 Sep; 4(5):762-5. PubMed ID: 9873885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal surgery with activated recombinant factor VII prophylaxis in patients with haemophilia A and high responding inhibitors: a report of five cases.
    Slaoui M; Lambert T; Stieltjes N; Claeyssens S; Borel-Derlon A;
    Blood Coagul Fibrinolysis; 2004 Oct; 15(8):687-91. PubMed ID: 15613924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bilateral total knee arthroplasty in a patient with hemophilia A, high inhibitor titre and aneurysma spurium of the popliteal artery. A case report.
    Frauchiger LH; Harstall R; Kajahn J; Anderson S; Eggli S
    Swiss Med Wkly; 2010; 140():w13094. PubMed ID: 20734280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of bleeding in patients with haemophilia A with inhibitors: a systematic review.
    Lloyd Jones M; Wight J; Paisley S; Knight C
    Haemophilia; 2003 Jul; 9(4):464-520. PubMed ID: 12828680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trial.
    Pruthi RK; Mathew P; Valentino LA; Sumner MJ; Seremetis S; Hoots WK;
    Thromb Haemost; 2007 Oct; 98(4):726-32. PubMed ID: 17938794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-course use of recombinant factor VIIa in a haemophilia patient with inhibitor undergoing cataract surgeries.
    Pekçelen Y; Yavuz AS; Namli S; Gücükoglu A
    Blood Coagul Fibrinolysis; 2005 Sep; 16(6):445-6. PubMed ID: 16093736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful urgent neurosugery management with rFVIIa mega doses in a child with haemophilia A and high titre inhibitor.
    Banov L; Pavanello M; Piattelli G; Disma N; Severino M; Dufour C; Molinari AC
    Blood Coagul Fibrinolysis; 2014 Jul; 25(5):518-21. PubMed ID: 24509334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlling acute bleeding episodes with recombinant factor VIIa in haemophiliacs with inhibitor: continuous infusion and bolus injection.
    Chuansumrit A; Isarangkura P; Angchaisuksiri P; Sriudomporn N; Tanpowpong K; Hathirat P; Jorgensen LN
    Haemophilia; 2000 Mar; 6(2):61-5. PubMed ID: 10781189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
    Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful hemostasis during a major orthopedic operation by using recombinant activated factor VII in a patient with severe hemophilia A and a potent inhibitor.
    O'Marcaigh AS; Schmalz BJ; Shaughnessy WJ; Gilchrist GS
    Mayo Clin Proc; 1994 Jul; 69(7):641-4. PubMed ID: 8015327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor: advantages of administration by continuous infusion over bolus intermittent injections.
    Scaraggi FA; De Mitrio V; Marino R; Speciale V; Di Bari L; Petronelli M; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Jan; 10(1):33-8. PubMed ID: 10070833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.